It looks like you're new here. If you want to get involved, click one of these buttons!
Heads up, cancer researchers! Appistry (our commercial licensing partner for GATK and now MuTect) is announcing an upcoming webinar on best practices for somatic mutation studies using GATK and MuTect. Registration for the webinar is open to all (not just Appistry customers) so be sure to sign up for this. See the announcement on Appistry's website for more detailed information.
Geraldine Van der Auwera, PhD